Copper tripeptide (GHK-Cu) is a naturally occurring tripeptide that was first isolated from human plasma, but can also be found in saliva and urine. During wound healing, Copper tripeptide can be released from existing extracellular proteins by proteolysis and is used as a chemical attractant for inflammatory and endothelial cells. Copper tripeptide can increase the production of collagen, elastin, proteoglycan, and glycosaminoglycan mRNA in fibroblasts. Copper tripeptide is a natural regulator of multiple cellular pathways in skin regeneration. (Anti-aging)
Glycyl-L-histidine-L-lysine is a tripeptide composed of sequentially linked glycine, L-histidine, and L-lysine residues. Glycyl-L-histidine-L-lysine is a liver immunosuppressant with anti-anxiety effects. Glycyl-L-histidine-L-lysine and its copper complex show good skin tolerance.
Effect: Copper peptide was first isolated from human plasma in 1973 and was found to have wound repair functions in 1985. In 1999, researchers suggested that copper peptide and its copper complex could act as activators of tissue remodeling. It is also a signal peptide that promotes the degradation of large collagen aggregates outside scars, the synthesis of normal skin collagen, the production of elastin, proteoglycan, and glycosaminoglycan, the growth rate and migration of different cell types, and has anti-inflammatory and antioxidant responses.
CAS No. | 89030-95-5 | Molecular Weight | 402.916 |
Molecular Formula | C14H21CuN6O4 | Melting Point | N/A |
CAS No. | 49557-75-7 | Molecular Weight | 340.378 |
Density | 1.3±0.1 g/cm3 | Boiling Point | 831.0±65.0 °C at 760 mmHg |
Molecular Formula | C14H24N6O4 | Flash point | 456.4±34.3 °C |